[
    [
        {
            "time": "",
            "original_text": "【天风医药】集采点评：上海发布集采补充文件，保证中选药品优先地位",
            "features": {
                "keywords": [
                    "集采",
                    "补充文件",
                    "中选药品",
                    "优先地位"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【天风医药】集采点评：上海发布集采补充文件，保证中选药品优先地位",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "捡到宝了！盘点2019年最牛100股，它们能牛到2020吗？",
            "features": {
                "keywords": [
                    "2019年",
                    "最牛100股",
                    "2020年"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "捡到宝了！盘点2019年最牛100股，它们能牛到2020吗？",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 3,
                "Market_Scope": 5,
                "Time_Proximity": 4,
                "Headline_Structure": 8,
                "Source_Recency": 3
            }
        },
        {
            "time": "",
            "original_text": "新一轮带量采购下的“洗牌”：仿制药升级淘汰加剧 医药板块持续分化",
            "features": {
                "keywords": [
                    "带量采购",
                    "洗牌",
                    "仿制药",
                    "升级淘汰",
                    "医药板块",
                    "持续分化"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "新一轮带量采购下的“洗牌”：仿制药升级淘汰加剧 医药板块持续分化",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]